GLP 3 is an investigational multi receptor peptide studied for its activity across the GLP 1, GIP, and glucagon receptor pathways—three signaling systems central to metabolic regulation. Its broad receptor profile has made it a major point of interest in contemporary metabolic and endocrine research. In research settings, GLP 3 has been explored for its relevance to appetite signaling, energy balance, glucose metabolism, and body weight regulation. Because it engages multiple metabolic pathways simultaneously, it has become a frequent subject of interest in comparative studies involving next generation incretin and multi agonist compounds. Published literature and ongoing investigational work have contributed to growing interest in GLP 3 as a tool for studying receptor synergy, metabolic signaling, and downstream effects on endocrine function. Its extended activity profile has also made it useful in longer horizon experimental models where sustained pathway engagement is relevant. This product is supplied as a high purity lyophilized powder for controlled laboratory handling by qualified research professionals.
CAS#: 2381089-83-2 Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈ Molecular Weight: 4,731.4 Compound GLP 3 Multi Agonist Form Lyophilized powder Storage Store in a cool, dry environment. Protect from moisture, heat, and direct light. Solubility Soluble in sterile or bacteriostatic water under controlled laboratory conditions.
Metabolic regulation and obesity related research models Appetite signaling and energy balance studies GLP 1, GIP, and glucagon receptor pathway analysis Glucose metabolism and insulin signaling research Comparative evaluation of multi agonist peptide systems Endocrine and longitudinal metabolic pathway investigations
This material is supplied exclusively for laboratory research use by qualified professionals. It is not intended for human or animal consumption, and must not be used in food, drugs, cosmetics, or diagnostic applications. All handling and use should comply with applicable laws, regulations, and institutional protocols.
